ch.oddb.org
  
Information professionnelle sur Myrtaven®:IBSA Institut Biochimique SA
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
C05CX99 - Andere kapillarstabilisierende Mittel (Diverse)ATC-DDD Version 2016. Source: WHO
C - Cardiovascular System

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.

C05 - Vasoprotectives
 

No DDDs are established in this group, since most of the drugs in this group are for topical use.

C05C - Capillary Stabilizing Agents
 
C05CX - Other Capillary Stabilizing Agents

Lysine aescinate is classified in C05CX03.

C05CX99 - Andere kapillarstabilisierende Mittel (Diverse)
2025 ©ywesee GmbH
Aide | FAQ | Contact | Home